Can cholestyramine be used in patients with cirrhosis, and what are its side effects?

Can Cholestyramine Be Given in Cirrhosis?

Yes, cholestyramine can be used in patients with cirrhosis, particularly for treating pruritus associated with cholestatic liver disease, but it should be used with caution and is generally considered second-line therapy after rifampicin. 1

Use in Cirrhosis

For Hepatic Pruritus (Primary Indication)

Cholestyramine is specifically indicated for pruritus associated with partial biliary obstruction, which includes patients with primary biliary cirrhosis 2. The 2018 British Association of Dermatologists guidelines recommend:

• Consider cholestyramine as second-line treatment for hepatic pruritus (after rifampicin fails) 1
• Rifampicin should be first-line (150-600 mg daily), with cholestyramine relegated to second-line due to limited evidence and tolerability issues 1

The 2009 EASL guidelines for cholestatic liver diseases recommend cholestyramine 4g up to four times daily as first-line treatment for pruritus, though this predates the stronger evidence for rifampicin 3. The 2018 UK-PBC guidelines note that cholestyramine is considered safe during pregnancy for pruritus management 4.

Hepatic Reserve Considerations

Important caveat: Research demonstrates that patients with compensated cirrhosis have significantly decreased capacity for bile acid synthesis compared to those with chronic hepatitis 5. A cholestyramine loading test showed cirrhotic patients had only 1.70-fold increase in bile acid synthesis versus 5.71-fold in controls, indicating reduced hepatic reserve 5.

Dosing and Administration

• Start low: Begin with 4g once daily, titrate gradually to minimize side effects 6
• Maximum dose: Up to 24g daily (4g four times daily) 3
• Timing: Must be spaced at least 4 hours away from other medications and UDCA to avoid binding interactions 3, 6

Side Effects

Common Gastrointestinal Effects

The most frequent adverse reactions include 2:

• Constipation (most common, especially in elderly >60 years and high doses)
• Abdominal discomfort/pain
• Flatulence, bloating
• Nausea, vomiting
• Diarrhea, steatorrhea

Serious Metabolic Complications in Cirrhosis

Critical warning: Cholestyramine can cause hyperchloremic metabolic acidosis in cirrhotic patients, particularly those with primary biliary cirrhosis 7, 8. This is especially dangerous when combined with:

• Volume depletion
• Renal impairment
• Spironolactone use 8

One case report documented severe acidosis (pH 7.15) in a 70-year-old woman with primary biliary cirrhosis taking cholestyramine 11 sachets twice daily, requiring 600 mEq IV sodium bicarbonate 7.

Nutritional Deficiencies

Long-term use can cause 2, 6:

• Vitamin K deficiency → bleeding tendencies, hypoprothrombinemia
• Vitamin A deficiency (night blindness reported)
• Vitamin D deficiency → osteoporosis risk
• Folate deficiency

Monitoring recommendation: While consensus is lacking, consider checking fat-soluble vitamins (A, D, K) and INR periodically during long-term therapy, especially in cirrhotic patients 6. Supplement vitamins A, D, and K only if deficiency occurs 6.

Rare but Serious Events

• Intestinal obstruction (including pediatric deaths reported) 2
• Calcified material in biliary tree 2

Drug Interactions

Major concern in cirrhosis patients who are typically on multiple medications 6:

Must separate by 4 hours from:

• Warfarin (monitor INR frequently)
• Thyroid preparations
• Diuretics (furosemide, hydrochlorothiazide)
• Digoxin
• Phenobarbital
• Antibiotics (tetracycline, penicillin G)

Contraindications and Precautions

Avoid in:

• Complete biliary obstruction 9
• Bowel obstruction or gastroparesis 9
• Extensive ileal resection (>100cm) - can worsen steatorrhea 6
• Triglycerides >500 mg/dL 9

Use with extreme caution in:

• Decompensated cirrhosis (Child-Pugh B or C) - higher risk of metabolic acidosis
• Concurrent spironolactone therapy 7, 8
• Renal impairment 8
• Volume-depleted patients 8

Clinical Algorithm for Pruritus in Cirrhosis

1. First-line: Rifampicin 150mg twice daily, increase to 600mg twice daily as needed 1
2. Second-line: Cholestyramine 4g daily, titrate up to 16g daily (monitor for constipation, acidosis)
3. Third-line: Sertraline 1
4. Fourth-line: Naltrexone or nalmefene 1

Bottom Line

Cholestyramine can be safely used in compensated cirrhosis for pruritus, but requires careful monitoring for metabolic acidosis, vitamin deficiencies, and drug interactions. It is now considered second-line after rifampicin based on stronger efficacy data for the latter. Avoid in decompensated cirrhosis, volume depletion, or when combined with spironolactone without close monitoring. Always separate administration from other medications by 4 hours and consider prophylactic laxatives to prevent constipation-induced hepatic encephalopathy.